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SHORT COMMUNICATION
MHC class II-expressing thymocytes suppress invariant
NKT cell development
Wei Li1,6, M Hanief Sofi2,6, Datsen G Wei3, Wenjun Du4, Jacquelyn Gervay-Hague4,
Gourapura J Renukaradhya1, Randy R Brutkiewicz1,5 and Cheong-Hee Chang2
Natural killer T (NKT) cells are positively selected on cortical thymocytes expressing the non-classical major histocompatibility
complex (MHC) class I CD1d molecules. However, it is less clear how NKT cells are negatively selected in the thymus. In this
study, we investigated the role of MHC class II expression in NKT cell development. Transgenic mice expressing MHC class II
on thymocytes and peripheral T cells had a marked reduction in invariant NKT (iNKT) cells. Reduced numbers of iNKT cells
correlated with the absence of in vivo production of cytokines in response to the iNKT cell agonist a-galactosylceramide. Using
mixed bone marrow chimeras, we found that MHC class II-expressing thymocytes suppressed the development of iNKT cells
in trans in a CD4-dependent manner. Our observations have significant implications for human iNKT cell development as human
thymocytes express MHC class II, which can lead to an inefficient selection of iNKT cells.
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Natural killer T (NKT) cells are a specialized subset of T cells that
coexpress NK cell markers, such as NK1.1. They originate in the thymus
and are positively selected by CD1d on cortical CD4 and CD8 double-
positive (DP) thymocytes.1–3 There are at least two sub-populations of
NKT cells based on their T-cell receptor (TCR) diversity.1 The major
subset is called invariant NKT (iNKT) cells because their TCR reper-
toire is highly limited, with the majority of them carrying the invariant
Va14–Ja18 a-chain paired mostly with one of the three Vb chains
(Vb8.2, Vb7 and Vb2) in mice. The other subset has a diverse TCR
repertoire and represents the non-invariant NKT cells.
Invariant NKT cells can be negatively selected when iNKT TCR
receives too strong signal.2–4 The addition of iNKT cell agonist
a-galactosylceramide (a-GalCer) to fetal thymic organ culture leads
to iNKT cell deletion,5,6 and the transgenic expression of CD8a and
CD8b chains in T cells also results in a reduction of iNKT cells.7
Transgenic mice overexpressing the NK-activating receptor LY49D
have reduced iNKT cell development.8 Furthermore, the overexpres-
sion of CD1d in dendritic cells decreased the number of iNKT cells.6,9
Unlike murine NKT cells, the number of Va24+ iNKT cells in
humans is highly variable among individuals and they represent only a
small portion of total NKT cells, whereas non-invariant NKT cells are
the major population.1,10–14 Human thymocytes can express not only
CD1 but also major histocompatibility complex (MHC) class II.15
However, it is not known whether MHC class II on thymocytes plays
a role during NKT cell development because murine thymocytes do
not express MHC class II. In this study, we showed that MHC class
II-expressing thymocytes suppress the development of iNKT cells
partly due to the interaction of MHC class II with CD4.
RESULTS AND DISCUSSION
To study the effect of MHC class II expression on NKT cell develop-
ment, we utilized mice that express MHC class II in thymocytes and
peripheral T cells by introducing the MHC class II transactivator
(CIITA) gene as a transgene (CIITATg).16 CIITATg mice had reduced
thymic NK1.1+TCRb+ NKT cells but not in the periphery (Figure 1a).
We next examined iNKT cells using CD1d tetramers loaded with
a-GalCer (hereafter referred to as tetramers) that specifically identify
iNKT cells. As shown in Figures 1b and c, CIITATg mice exhibited a
marked reduction in iNKT cells both in the thymus and the peripheral
tissue, indicating that CIITA expression in T cells led to a selective
failure of iNKT development and a corresponding expansion of non-
invariant NKT cells. The reduction in iNKT cell number was MHC
haplotype independent (Figure 1d). However, unlike CD1d/ mice
that had no iNKT cells, residual iNKT cells were present in CIITATg
mice (Figure 1b). These residual iNKT cells in the CIITATg thymus
seemed to have undergone proper developmental stages and become
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mature iNKT cells as defined by CD44 and NK1.1 expression, albeit a
slight increase and decrease in the percentages of immature and the
most mature iNKT cells, respectively (Figure 1e). The decrease in
iNKT cell number in the periphery resulted in very little circulating
interleukin-4 or interferon-g upon in vivo activation (Supplementary
Figure 1a). The CD1d levels on CIITATg DP thymocytes (Suppleme-
ntary Figure 1b) were comparable with wild-type (WT) cells.
As CIITA can turn on the expression of multiple genes involved in
MHC class II antigen presentation, such as the invariant chain (Ii),17
we wanted to determine whether the expression of MHC class II
or a gene product regulated by CIITA is responsible for the
observed inefficient iNKT cell development. To do this, we generated
CIITATg mice lacking MHC class II by crossing them with MHC
class II-deficient Abb/ mice (CIITATg/Abb/). In these mice, devel-
oping thymocytes express the CIITA transgene but not MHC class II.
The absence of MHC class II in CIITATg/Abb/ mice significantly
improved the generation of iNKT cells (Figures 2a and b), suggesting
that MHC class II participates in the development of iNKT cells. The
incomplete restoration implies the possible involvement of other
CIITA-regulated components in iNKT cell development. One putative
candidate is Ii, which is known to associate with CD1d in endosomes
and enhance CD1d antigen presentation of dendritic cells and B cells
to iNKT cells.18 Further study is required to determine whether
Ii plays a suppressive role in iNKT cell development.
To test whether MHC class II-expressing thymocytes fail to develop
into iNKT cells in a cell autonomous manner, we constructed mixed
bone marrow (BM) chimeric mice. Different CD45 markers were used
to distinguish cells derived from the two different BM sources and the
host. In WT+WT-B6.SJL mice, each WT BM population generated
a sizable iNKT cell population (Figure 2c, left group; Supplementary
Figure 2). However, in the presence of CIITATg BM, WT BM cells
failed to generate a comparable proportion of iNKT cells, implying
that MHC class II-expressing thymocytes suppress neighboring thy-
mocytes to progress to iNKT cells in trans (Figure 2c, right group;
Supplementary Figure 2).
To further substantiate the role of MHC class II in iNKT
cell development, we cotransferred WT BM cells together with
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Figure 1 Reduction of iNKT cells in CIITATg mice. Expression of TCRb and NK1.1 markers (a) or TCRb and tetramer (b) on indicated cell types from WT
(CIITATg littermates), CIITATg and CD1d/ mice. The number in the dot plots represents the percentage of NK1.1+TCRb+ NKT cells (a) or iNKT cells (b).
Mice used were 10–11 weeks old and similar results were obtained from at least four mice per group. (c) Absolute numbers of iNKT cells. Values are
mean±s.d. of iNKT cells present in the thymi (n¼10), spleens (n¼6) and livers (n¼4). Mice were 2–3 months old. (d) Representative iNKT cell staining of
three pairs of WT (CIITATg littermates) and CIITATg on the H-2d background. (e) Analysis of NK1.1 and CD44 expression on thymic iNKT cells.
Tetramer+HSAlo cells were gated and percentages of cells in each quadrant are shown. Results are representative of four pairs of WT and CIITATg littermates.
Mice were 10 weeks old. iNKT cells, invariant natural killer T cells; TCR, T-cell receptor; WT, wild type.
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itself is responsible for deleting thymocytes, iNKT cell development
should be restored in WT+CIITATg/Abb/ -B6.SJL mice. Indeed,
iNKT cells originated from WT BM were present at a normal level
(compare the second row in Figure 2d with the right group in
Figure 2c; Supplementary Figure 2). In the control WT+Abb/-
B6.SJL chimeras, WT iNKT cells were also generated (Figure 2d, top
row; Supplementary Figure 2). Earlier, overexpressing CD1d on DC
that also express MHC class II led to a negative selection of iNKT
cells.6,9 Therefore, we asked whether coexpression of CD1d together
with MHC class II on the same cells is necessary to delete iNKT cells.
iNKT cells derived from WT BM were dramatically decreased in the
presence of CIITATg/CD1d/ thymocytes, indicating the unlikely role
of CD1d in the deletion of iNKT cells (Figure 2d, third row;
Supplementary Figure 2). Finally, MHC class II on the thymocyte
surface might function as a coreceptor for CD4 molecules, enhancing
the avidity of TCR on NKT progenitors that are being selected. If so,
the strength of signaling could reach beyond the threshold for the
survival of cells. Indeed, in the CD4/+CIITATg-B6.SJL chimeras,
CD4/ thymocytes were developed to iNKT cells normally in the
presence of MHC class II-expressing thymocytes (Figure 2d, bottom
row; Supplementary Figure 2), suggesting that the interaction of MHC
class II with CD4 is at least partly responsible for the disappearance of
iNKT cells. Thus, in addition to its role in iNKT cell activation,19,20




















































































Figure 2 MHC class II inhibits iNKT cell development. (a) MHC class II expression in thymocytes is necessary for the inhibition of iNKT cell generation. Total
thymocytes from the indicated mice were analyzed for TCRb and tetramer reactivity. WT and CIITATg mice on the Abb+/ and Abb/ background were
littermates. Results are representative of at least four experiments. (b) Relative percentages of thymic iNKT cells in at least eight mice of Abb+/, CIITATg/
Abb+/, CIITATg /Abb/ or Abb/. The value of the percentage of iNKT cells in WT mice was set at 100%. Mice were 2–3 months old. (c) Suppression of
iNKT cell development by MHC class II-expressing thymoyctes in trans. BM cells from WT (CD45.2) and WT (CIITATg littermates; CD45.1/CD45.2) or WT
(CD45.2) together with CIITATg (CD45.1/CD45.2) were coinjected into B6.SJL (CD45.1) recipients. Shown at the top is the composition of total thymocytes
in reconstituted mice. TCRb versus tetramer profiles of thymocytes are shown at the bottom. Chimeras were analyzed 10–12 weeks post-BM transplantation.
(d) MHC class II and CD4 expression is required for the disappearance of iNKT cells in mixed BM chimeric mice as indicated. BMs were prepared from WT
(CD45.1/2), Abb/ (CD45.2), CIITATg/Abb/ (CD45.2), CIITATg/CD1d/ (CD45.2), CIITATg (CD45.1/2) and CD4/ (CD45.2) mice and transferred to
B6.SJL mice. The number in the dot plots represents the percentage of iNKT cells developed from WT BM cells except the bottom group that shows CD4/
iNKT cells. Chimeras were analyzed 2–3 months post-BM transplantation. BM, bone marrow; iNKT, invariant natural killer T cells; MHC, major
histocompatibility complex; TCR, T-cell receptor; WT, wild type.
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As iNKT cells are mainly composed of CD4+ and CD4-CD8- double-
negative sub-populations, it would be interesting to test whether the
interaction between MHC class II and CD4 would preferentially affect
the development of CD4+ iNKT subset.
Taken all together, we have demonstrated, for the first time, that
MHC class II plays an important role during iNKT cell development.
Similar to CIITATg mice, humans have much fewer iNKT cells than
non-invariant NKT cells compared with mice. Perhaps, this is related
to the fact that human fetal and neonatal thymocytes express MHC
class II, which likely plays an inhibitory role in iNKT cell generation.
The final tuning of the strength of the signal delivered by CD1d and/or
MHC class II may be critical for survival or death of developing
thymocytes to progress toward iNKT cells.
METHODS
Mice
Mice carrying the human type III CIITA transgene (CIITATg), CIITATg mice on the
MHC class II-deficient Abb/ background (CIITATg/Abb/) and CD1d/ on
the C57BL/6 background were described earlier.15,16,21 CIITATg and CD1d/
mice were backcrossed with C57BL/6 (B6) mice at least six to eight times,
respectively. CIITATg mice on the Balb/c background were backcrossed six
times. CD4/ mice were purchased from the Jackson Laboratory (Bar Harbor,
ME, USA) and C57BL/6.SJL (B6.SJL) mice from Taconic (Germantown, NY,
USA). Non-CIITATg littermates from heterozygous CIITATg breeding were used
as WT controls. CIITATg and WT mice were also bred to carry CD45.1 and
CD45.2 congenic markers. All mice were housed in the animal facility at the
Indiana University School of Medicine or the University of Michigan Medical
School under specific pathogen-free conditions and used at 6–12 weeks of age.
All animal experiments were performed under protocols approved by the
institutions.
Mixed bone marrow chimeras
Preparation of mature lymphocyte-depleted BM cells and BM transfers were
performed as described earlier.15 To generate mixed BM chimeras, BM cells
from two different types of donor mice were mixed at a ratio of 1:1 and each
lethally irradiated recipient mouse (950 rad) was infused with 2–5105 cells
through tail vein injection.
Flow cytometry
All antibodies used for flow cytometry were purchased from BD Biosciences
(San Diego, CA, USA). Cells were pre-incubated with the anti-FcgR mAb 2.4G2
to block nonspecific antibody binding before staining with the following
fluorescein isothiocyanate-, phycoerythrin-, PerCP-, CyChrome-, allophycocya-
nin- or biotin-conjugated antibodies: TCRb (H57), CD4 (L3T4), B220
(RA3-6B2), NK1.1 (PK136), CD1d (1B1), CD45.1 (A20) and CD45.2 (104).
Fluorochrome-conjugated streptavidin was used to visualize staining by bioti-
nylated primary antibodies. Allophycocyanin-conjugated CD1d-a-GalCer tet-
ramers were generously provided by Dr Albert Bendalac from the University of
Chicago and the NIH Tetramer Facility. Events were acquired on a FACSCa-
libur or FACSCanto (BD Biosciences) flow cytometer and the data were
analyzed using the CELLQuest Pro or FlowJo software.
In vivo cytokine production assay
Mice were injected i.v. with 2mg a-GalCer22 or vehicle in 100ml of phosphate-
buffered saline. After 2 h, mice were killed and serum interleukin-4 and
interferon-g were detected using enzyme-linked immunosorbent assay kits
(BD Biosciences).
Statistical analysis
The non-parametric Wilcoxon rank sum test was performed to calculate
statistical significance. P-values less than 0.05 were considered statistically
significant.
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